An effective immune response leads to rapid elimination of infectious agents, with seemingly little long-term impairment to the host. New findings by Morais da Fonseca et al. reveal that acute infections may result in permanent disruption of tissue homeostasis and immune dysfunction, long after clearance of a pathogen.
Throughout the course of one's lifetime, an individual will experience numerous episodes of acute and chronic microbial infection-including, but not limited to, gastrointestinal and respiratory infections. Exposure to certain pathogens has been shown to have profound, long-lasting consequences on the function of the host immune responses (Medzhitov, 2008 (Medzhitov, , 2010 , with some chronic infections proposed as triggers for inflammatory disorders such as multiple sclerosis, lupus, and inflammatory bowel disease (IBD) (Karin et al., 2006; Wucherpfennig, 2001) . In contrast, acute infections are typically considered self-limiting without engendering long-term immune consequences to the host, though resolution nevertheless requires an inflammatory response and disruption of tissue homeostasis. In this issue of Cell, Morais da Fonseca et al. reveal that a single acute infection with the enteric pathogen Yersinia pseudotuberculosis results in a permanent dysregulation of tissue-specific immunity (Morais da Fonseca et al., 2015) . Long after clearance of Yersinia, the infection appears to cause persistent impairment of the lymphatic network, disrupting molecular and cellular interactions between the gut and mesenteric lymph nodes (MLN), resulting in impaired mucosal immune responses (Figure 1 ). This exciting new study reveals that acute infections may contribute to long-term disruption of tissue homeostasis, promoting chronic immune dysfunction and disease.
While most interactions between microbes and animals are symbiotic in nature, the immune system has been shaped by an evolutionary ''arms race'' with pathogens. Examples of chronic infections resulting in persistent inflammation and localized tissue damage include Mycobacterium tuberculosis (tuberculosis), Helicobacter pylori (peptic ulcers and gastric cancer), hepatitis B virus and hepatitis C virus (chronic hepatitis and cirrhosis), and Borrelia burgdorferi (Lyme disease) (Karin et al., 2006; Wucherpfennig, 2001 ). However, there are fewer examples illustrating how acute infections may be linked to permanent alterations to host immunity. Rheumatic fever, an inflammatory disease involving the heart and joints, develops following an acute, self-limiting infection of the pharynx with group A Streptococcus pyogenes. A pathological consequence of molecular mimicry, the immune response to streptococcal M protein elicits cross-reactivity to human protein antigens, specifically myosin, tropomyosin, and laminin in cardiac myocytes. However, whether acute infections permanently alter general immune function has remained unclear, as has evidence that a pathogen can trigger chronic inflammatory diseases after its clearance by the immune system. Here, Morais da Fonseca et al. report that after an acute gastrointestinal infection with Y. pseudotuberculosis, 70% of mice develop chronic mesenteric lymphadenopathy (CL + ) despite clearance of Yersinia. In a series of elegant experiments, the authors reveal that infection-induced tissue damage and remodeling of mesenteric lymphoid tissues promotes impaired integrity of the lymphatic network, as shown by leakage of fluorescent BODIPY from lymphatic vessels into the surrounding mesenteric adipose tissue (MAT). As a result of increased lymphatic permeability, migratory CD103 + CD11b + DCs were shown to accumulate in the MAT compartment rather than transiting to MLNs as expected (Figure 1 ), thereby blunting robust mucosal immune responses. Notably, the defect in lymphatic integrity persisted at least nine months post-Yersinia infection, suggesting durable pathologic consequences well after clearance of the pathogen. A similar finding was previously reported where respiratory tract infection with Mycoplasma pulmonis led to persistent lymphangiogenesis and reduced transport of antigen presenting cells from the airways to draining lymph nodes (Baluk et al., 2005) . Morais da Fonseca and coworkers extend these previous concepts to reveal a mechanism whereby tissue damage caused during acute gastrointestinal infection impairs proper mucosal immune function. Specifically, pathogeninduced reduction in trafficking of migratory gut DCs to the MLN compromises the ability of these cells to promote oral tolerance and protective immunity to oral vaccination. The authors proceed to show that the microbiota is required to sustain inflammation after resolution of Yersinia. Germ-free (GF) mice infected with Y. pseudotuberculosis developed lymphadenopathy, similar to specific-pathogen free (SPF) mice. However, migration dynamics of CD103 + CD11b + DCs from the lamina propria to MLNs remained unaffected in GF mice, suggesting that Yersinia infection causes mislocalization of DCs to the MAT via effects on the microbiota. Antibiotic treatment depleting the microbiota in SPF mice was sufficient to reduce cell infiltration into the surrounding MAT, restoring proper DC trafficking and robust mucosal immunity, further implicating the microbiota as a vehicle for sustained immune dysregulation following resolution of acute infection. It is important to note, however, that the development of chronic lymphadenopathy was not associated with either a bloom of pathogenic bacterial strains (pathobionts) or dysbiosis of the gut microbiota, as lymphadenopathy was not transmissible via co-housing or fecal transplant into uninfected GF mice. Rather, it was likely due to enhanced exposure of the immune system to gut microbial ligands as a result of defective lymphatic integrity, as treatment with bacterial products alone was able to promote and sustain inflammation following enteric infection.
As features of chronic inflammatory diseases typically mirror immune responses to acute infection, identification of a direct link between a causal infectious agent and chronic disease has been challenging. For Crohn's disease, a chronic inflammatory condition of the gastrointestinal tract, many, including Crohn and colleagues, have postulated an inciting infectious agent may be responsible for the initiation of disease (Crohn et al., 1984; Hugot et al., 2003; Sartor, 2005) . Despite extensive research efforts, a causative organism(s) for Crohn's disease has yet to be reproducibly validated, though this issue remains controversial (Greenstein, 2003) . Perhaps chronic inflammation observed in Crohn's patients may be the result of persistent effects of a previously encountered infection that caused a long-lasting impairment of the immune system. The study by Morais da Fonseca et al. provides a novel framework to examine how a cleared infection may induce permanent tissue remodeling and altered immune responses, contributing to chronic disease later in life. However, outstanding questions remain despite these comprehensive advances; namely the mechanism by which Yersinia promotes chronic lymphadenopathy remains unresolved. What cellular and molecular changes to the host impair integrity of lymphatic vessels? Are there specific bacterial factors that are required for this outcome? Further, it is unknown why certain populations of mice undergo lymphatic remodeling, whereas others (cage mates) are protected from lymphadenopathy. Not surprisingly, the outcomes uncovered by this new study are unlikely to be specific to Yersinia pathogenesis as the authors showed Toxoplasma gondii infection, as well as T cell transfer of colitis, are both sufficient to promote chronic lymphadenophathy. These data suggest that chronic inflammatory diseases may be caused by acute infections and are a consequence of a generalized host response. Collectively, the innovative findings from Morais da Fonseca and coworkers reveal an intriguing hypothesis whereby remodeling of the immune system by an acute infection may cause chronic tissue-specific damage and symptoms associated with IBD and autoimmunity and may help explain a possible etiology of various idiopathic inflammatory conditions. Under normal conditions (left), migratory CD103 + CD11b + DCs recognize and internalize antigens from the gut and traffic to MLNs via lymphatic vessels. In the MLNs, CD103 + CD11b + DCs induce TREG and TH17 responses to promote oral tolerance and protective immunity to oral vaccination. Following the clearance of Yersinia pseudotuberculosis (right), infection-induced tissue damage leads to increased permeability of the lymphatic network. As a result, migratory DCs accumulate in the MAT compartments rather than trafficking to MLNs, blunting TREG and TH17 responses. The microbiota sustains inflammation following clearance of Yersinia, as enhanced exposure to microbial ligands occur due to increased permeability of the lymphatic system. MLN, mesenteric lymph nodes; MAT, mesenteric adipose tissues.
